APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Selected research

Market Structure

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchEnzyme-Linked Immunosorbent Assay (ELISA) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.

China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.

Read the full market overview

In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.

Report Includes

This report provides an overview of the global Enzyme-Linked Immunosorbent Assay (ELISA) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enzyme-Linked Immunosorbent Assay (ELISA) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enzyme-Linked Immunosorbent Assay (ELISA) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Enzyme-Linked Immunosorbent Assay (ELISA) market size, projected growth trends, production technologies, key applications, and end-use industries.

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Company

R&D Systems

Thermo Fisher Scientific

Ortho Clinical Diagnostics

BD Biosciences

ZEUS Scientific

Bio-Rad Laboratories

ALPCO

Enzo Life Sciences

BioMérieux

EMD Millipore

BioLegend

LOEWE Biochemica

Mercodia

Cusabio

Shanghai Kehua Bio-engineering

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Type

Sandwich ELISA

Indirect ELISA

Competitive ELISA

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Application

Immunology

Inflammation

Infectious Diseases

Cancer

Protein Quantitation

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enzyme-Linked Immunosorbent Assay (ELISA) industry.

Chapter 3: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enzyme-Linked Immunosorbent Assay (ELISA)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Sandwich ELISA Table 3. Key Players of Indirect ELISA Table 4. Key Players of Competitive ELISA Table 3. Key Players of Others Table 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Immunology Table 6. Key Players of Inflammation Table 7. Key Players of Infectious Diseases Table 8. Key Players of Cancer Table 9. Key Players of Protein Quantitation Table 10. Key Players of Others Table 11. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Region (2021-2026) Table 14. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Region (2027-2032) Table 16. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends Table 17. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Drivers Table 18. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Opportunities and Challenges Table 19. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Restraints Table 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Company (2021-2026) Table 22. Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Key Company Head Office and Area Served Table 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company, Product Type & Application Table 25. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Enzyme-Linked Immunosorbent Assay (ELISA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type (2021-2026) Table 32. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type (2027-2032) Table 33. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application (2021-2026) Table 37. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application (2027-2032) Table 38. R&D Systems Company Information Table 39. R&D Systems Business Overview Table 40. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 42. R&D Systems Recent Development Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. Ortho Clinical Diagnostics Company Information Table 49. Ortho Clinical Diagnostics Business Overview Table 50. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 52. Ortho Clinical Diagnostics Recent Development Table 53. BD Biosciences Company Information Table 54. BD Biosciences Business Overview Table 55. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 57. BD Biosciences Recent Development Table 58. ZEUS Scientific Company Information Table 59. ZEUS Scientific Business Overview Table 60. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 62. ZEUS Scientific Recent Development Table 63. Bio-Rad Laboratories Company Information Table 64. Bio-Rad Laboratories Business Overview Table 65. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 67. Bio-Rad Laboratories Recent Development Table 68. ALPCO Company Information Table 69. ALPCO Business Overview Table 70. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 72. ALPCO Recent Development Table 73. Enzo Life Sciences Company Information Table 74. Enzo Life Sciences Business Overview Table 75. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 77. Enzo Life Sciences Recent Development Table 78. BioMérieux Company Information Table 79. BioMérieux Business Overview Table 80. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 82. BioMérieux Recent Development Table 83. EMD Millipore Company Information Table 84. EMD Millipore Business Overview Table 85. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 87. EMD Millipore Recent Development Table 88. BioLegend Company Information Table 89. BioLegend Business Overview Table 90. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 92. BioLegend Recent Development Table 93. LOEWE Biochemica Company Information Table 94. LOEWE Biochemica Business Overview Table 95. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 97. LOEWE Biochemica Recent Development Table 98. Mercodia Company Information Table 99. Mercodia Business Overview Table 100. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 102. Mercodia Recent Development Table 103. Cusabio Company Information Table 104. Cusabio Business Overview Table 105. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 107. Cusabio Recent Development Table 108. Shanghai Kehua Bio-engineering Company Information Table 109. Shanghai Kehua Bio-engineering Business Overview Table 110. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 112. Shanghai Kehua Bio-engineering Recent Development Table 113. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026) & (US$ Million) Table 114. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032) & (US$ Million) Table 115. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026) & (US$ Million) Table 116. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032) & (US$ Million) Table 117. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) Table 119. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032) Table 120. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026) & (US$ Million) Table 121. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032) & (US$ Million) Table 122. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026) & (US$ Million) Table 123. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032) & (US$ Million) Table 124. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) Table 126. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032) Table 127. China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026) & (US$ Million) Table 128. China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032) & (US$ Million) Table 129. China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026) & (US$ Million) Table 130. China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032) & (US$ Million) Table 131. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026) & (US$ Million) Table 132. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032) & (US$ Million) Table 133. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026) & (US$ Million) Table 134. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032) & (US$ Million) Table 135. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) Table 137. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032) Table 138. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) Table 144. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Product Image Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type: 2025 VS 2032 Figure 4. Sandwich ELISA Image Figure 5. Indirect ELISA Image Figure 6. Competitive ELISA Image Figure 7. Others Image Figure 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application: 2025 VS 2032 Figure 10. Immunology Image Figure 11. Inflammation Image Figure 12. Infectious Diseases Image Figure 13. Cancer Image Figure 14. Protein Quantitation Image Figure 15. Others Image Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type (2021-2032) Figure 25. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application (2021-2032) Figure 27. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 28. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032) Figure 29. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032) Figure 30. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 31. United States Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 32. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 34. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 35. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032) Figure 36. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032) Figure 37. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 38. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 39. France Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 41. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 42. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 44. China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 45. China Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032) Figure 46. China Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032) Figure 47. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 48. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032) Figure 49. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032) Figure 50. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 51. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 55. India Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 56. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 61. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 66. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 68. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Sandwich ELISA
  • Indirect ELISA
  • Competitive ELISA
  • Others
Applications
  • Immunology
  • Inflammation
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Others
Companies covered
  • R&D Systems
  • Thermo Fisher Scientific
  • Ortho Clinical Diagnostics
  • BD Biosciences
  • ZEUS Scientific
  • Bio-Rad Laboratories
  • ALPCO
  • Enzo Life Sciences
  • BioMérieux
  • EMD Millipore
  • BioLegend
  • LOEWE Biochemica
  • Mercodia
  • Cusabio
  • Shanghai Kehua Bio-engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Sandwich ELISA
  5. 1.2.3 Indirect ELISA
  6. 1.2.4 Competitive ELISA
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Immunology
  11. 1.3.3 Inflammation
  12. 1.3.4 Infectious Diseases
  13. 1.3.5 Cancer
  14. 1.3.6 Protein Quantitation
  15. 1.3.7 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Growth Trends by Region
  18. 1.5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2021-2026)
  20. 1.5.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Dynamics
  1. 2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
  2. 2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Drivers
  3. 2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Opportunities and Challenges
  4. 2.4 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (2021-2026)
  2. 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Key Company Head office and Area Served
  4. 3.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company, Product Type & Application
  5. 3.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Enzyme-Linked Immunosorbent Assay (ELISA) Tier 1, Tier 2, and Tier 3
4 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Type
  1. 4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2032)
  3. 4.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Type (2021-2032)
5 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Application
  1. 5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2032)
  3. 5.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 R&D Systems
  2. 6.1.1 R&D Systems Company Information
  3. 6.1.2 R&D Systems Business Overview
  4. 6.1.3 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  6. 6.1.5 R&D Systems Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 Ortho Clinical Diagnostics
  14. 6.3.1 Ortho Clinical Diagnostics Company Information
  15. 6.3.2 Ortho Clinical Diagnostics Business Overview
  16. 6.3.3 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  18. 6.3.5 Ortho Clinical Diagnostics Recent Developments
  19. 6.4 BD Biosciences
  20. 6.4.1 BD Biosciences Company Information
  21. 6.4.2 BD Biosciences Business Overview
  22. 6.4.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  24. 6.4.5 BD Biosciences Recent Developments
  25. 6.5 ZEUS Scientific
  26. 6.5.1 ZEUS Scientific Company Information
  27. 6.5.2 ZEUS Scientific Business Overview
  28. 6.5.3 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  30. 6.5.5 ZEUS Scientific Recent Developments
  31. 6.6 Bio-Rad Laboratories
  32. 6.6.1 Bio-Rad Laboratories Company Information
  33. 6.6.2 Bio-Rad Laboratories Business Overview
  34. 6.6.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories Recent Developments
  37. 6.7 ALPCO
  38. 6.7.1 ALPCO Company Information
  39. 6.7.2 ALPCO Business Overview
  40. 6.7.3 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  42. 6.7.5 ALPCO Recent Developments
  43. 6.8 Enzo Life Sciences
  44. 6.8.1 Enzo Life Sciences Company Information
  45. 6.8.2 Enzo Life Sciences Business Overview
  46. 6.8.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  48. 6.8.5 Enzo Life Sciences Recent Developments
  49. 6.9 BioMérieux
  50. 6.9.1 BioMérieux Company Information
  51. 6.9.2 BioMérieux Business Overview
  52. 6.9.3 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  54. 6.9.5 BioMérieux Recent Developments
  55. 6.10 EMD Millipore
  56. 6.10.1 EMD Millipore Company Information
  57. 6.10.2 EMD Millipore Business Overview
  58. 6.10.3 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  60. 6.10.5 EMD Millipore Recent Developments
  61. 6.11 BioLegend
  62. 6.11.1 BioLegend Company Information
  63. 6.11.2 BioLegend Business Overview
  64. 6.11.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  66. 6.11.5 BioLegend Recent Developments
  67. 6.12 LOEWE Biochemica
  68. 6.12.1 LOEWE Biochemica Company Information
  69. 6.12.2 LOEWE Biochemica Business Overview
  70. 6.12.3 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  72. 6.12.5 LOEWE Biochemica Recent Developments
  73. 6.13 Mercodia
  74. 6.13.1 Mercodia Company Information
  75. 6.13.2 Mercodia Business Overview
  76. 6.13.3 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  78. 6.13.5 Mercodia Recent Developments
  79. 6.14 Cusabio
  80. 6.14.1 Cusabio Company Information
  81. 6.14.2 Cusabio Business Overview
  82. 6.14.3 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  84. 6.14.5 Cusabio Recent Developments
  85. 6.15 Shanghai Kehua Bio-engineering
  86. 6.15.1 Shanghai Kehua Bio-engineering Company Information
  87. 6.15.2 Shanghai Kehua Bio-engineering Business Overview
  88. 6.15.3 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  90. 6.15.5 Shanghai Kehua Bio-engineering Recent Developments
7 North America
  1. 7.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
  2. 7.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type
  3. 7.2.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026)
  4. 7.2.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032)
  5. 7.2.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032)
  6. 7.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application
  7. 7.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026)
  8. 7.3.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032)
  9. 7.3.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032)
  10. 7.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
  11. 7.4.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  13. 7.4.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
  14. 7.4.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
  2. 8.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type
  3. 8.2.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032)
  6. 8.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application
  7. 8.3.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032)
  10. 8.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
  11. 8.4.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
  2. 9.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type
  3. 9.2.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026)
  4. 9.2.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032)
  5. 9.2.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032)
  6. 9.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application
  7. 9.3.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026)
  8. 9.3.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032)
  9. 9.3.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
  2. 10.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type
  3. 10.2.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032)
  6. 10.3 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application
  7. 10.3.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032)
  10. 10.4 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
  11. 10.4.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst